Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to collect and evaluate real-world data on the effectiveness of deucravacitinib treatment in adults with moderate plaque psoriasis in China.
Official title: A Prospective Observational Study to Evaluate the Effectiveness of Deucravacitinib in Patients With Moderate Plaque Psoriasis in Real-World Settings in China (ADMIRE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2025-01-20
Completion Date
2026-08-31
Last Updated
2026-01-22
Healthy Volunteers
No
Conditions
Interventions
Deucravacitinib
As per product label
Locations (5)
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
The Affiliated Hospital of Hebei University of Engineering
Handan, Hebei, China
DaLian Dermatosis Hospital
Dalian, Liaoning, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Beijing Tsinghua Changgung Hospital
Beijing, China